Isotiorga

Isotretinoin, the active ingredient in Isotiorga, is a retinoid presented as an oral formulation for oral use. It is indicated for the treatment of severe recalcitrant nodular acne in patients who have not responded to conventional therapies. It belongs to the therapeutic class of retinoids and works by targeting sebaceous gland activity.

GNH USA supplies Isotiorga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice (GDP) standards, ensuring product integrity throughout the supply chain, and provides regulatory support for import and customs clearance.

Isotretinoin is a retinoid used in the management of severe acne. - Severe nodular acne: decreases inflammatory lesions and prevents new nodule formation. - Severe acne vulgaris: reduces overall lesion count and improves skin appearance. - Recalcitrant acne: provides therapeutic benefit when other systemic treatments have failed.

Common Side Effects: - Dry skin: increased transepidermal water loss causing roughness. - Cheilitis: cracking and inflammation of the lips. - Photosensitivity: heightened skin reaction to sunlight. - Elevated triglycerides: rise in blood lipid levels. - Headache: mild to moderate head discomfort. - Musculoskeletal pain: aches in joints or muscles.

Serious or Rare Side Effects: - Severe depression or suicidal ideation: mood changes requiring immediate evaluation. - Hepatotoxicity: significant elevation of liver enzymes. - Pancreatitis: inflammation of the pancreas with abdominal pain. - Pseudotumor cerebri: increased intracranial pressure presenting with visual disturbances. - Birth defects: severe fetal malformations if exposure occurs during pregnancy. - Severe hypercalcemia: elevated calcium levels causing systemic symptoms.

Isotretinoin requires careful monitoring due to its potency and risk profile. - Pregnancy: contraindicated; ensure effective contraception before, during, and after therapy. - Liver function: monitor hepatic enzymes regularly. - Lipid profile: assess triglycerides and cholesterol periodically. - Mood changes: observe for signs of depression or suicidal thoughts. - Vitamin A intake: avoid concurrent high‑dose vitamin A supplements. - Store below 25°C: keep in the original pack, protect from moisture.

Isotretinoin may interact with several medications, necessitating vigilance. Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of intracranial hypertension. - Vitamin A supplements: additive toxicity leading to hypervitaminosis A. - Systemic retinoids: cumulative retinoid toxicity. Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduced efficacy, consider alternative contraception. - Corticosteroids: may exacerbate mood disturbances. - Warfarin: potential alteration of anticoagulant effect, monitor INR.